Table 6.
Resistance patterns of ESBL producing isolates
| Antibiotics | E. coli (%) | K. pneumoniae (%) | Total (%) |
|---|---|---|---|
| Co-trimoxazole | 28 (60.9) | 8 (53.3) | 36 (59) |
| Cephalexin | 46 (100) | 15 (100) | 61 (100) |
| Amoxicillin | 46 (100) | 15 (100) | 61 (100) |
| Amikacin | 3 (6.5) | 2 (13.3) | 5 (8.2) |
| Ciprofloxacin | 28 (60.9) | 8 (53.3) | 36 (59) |
| Ofloxacin | 28 (60.9) | 8 (53.3) | 36 (59) |
| Ceftriaxone | 40 (87) | 13 (86.7) | 53 (86.9) |
| Ceftazidime | 43 (93.5) | 15 (100) | 58 (95.1) |
| Cefotaxime | 45 (97.8) | 15 (100) | 60 (98.4) |
| Cefoperazone/sulbactam | 1 (2.2) | 2 (13.3) | 3 (4.9) |
| Pipercillin/tazobactam | 2 (4.3) | 2 (13.3) | 4 (6.6) |
| Imipenem | 0 (0) | 0 (0) | 0 (0) |